AstraZeneca's Tagrisso to cost $12,750 for a month's supply

Reuters

17 November 2015 - A company spokeswoman said on Tuesday the wholesale acquisition cost was comparable to other targeted oral cancer therapies, including AstraZeneca's Iressa.

For more details, go to: http://www.reuters.com/article/2015/11/17/astrazeneca-cancer-tagrisso-idUSL8N13C1TU20151117#oaqsLdej5mURdZGp.97

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US , Pricing